Evidence map›Paper›PMID 40239194›Full record

ArticleJMIR research protocols2025

Testing a Machine Learning-Based Adaptive Motivational System for Socioeconomically Disadvantaged Smokers (Adapt2Quit): Protocol for a Randomized Controlled Trial.

Ariana Kamberi, Benjamin Weitz, Julie Flahive, Julianna Eve, Reem Najjar, Tara Liaghat, Daniel Ford, Peter Lindenauer, Sharina Person, Thomas K Houston and 4 more

Erratum issued Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04720625 (Adapt2Quit - A Machine-Learning, Adaptive Motivational System), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04720625 nacompletednot on this map

Adapt2Quit - A Machine-Learning, Adaptive Motivational System: RCT for Socio-Economically Disadvantaged Smokers

TypeinterventionalSponsorUniversity of Massachusetts, WorcesterRan2021 to 2025Enrolled757ConditionsTobacco SmokingArmsAdapt2Quit, Control
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ariana KamberiDivision of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0000-0001-5363-825X
Benjamin WeitzDivision of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0009-0000-0532-0781
Julie FlahiveDivision of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0000-0002-2786-7144
Julianna EveDepartment of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School-Baystate, Springfield, MA, United States.ORCID 0000-0003-2763-1630
Reem NajjarDivision of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0009-0008-7248-635X
Tara LiaghatInstitute for Clinical and Translational Research, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.ORCID 0009-0006-2882-2710
Daniel FordInstitute for Clinical and Translational Research, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.ORCID 0000-0002-2549-2289
Peter LindenauerDepartment of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School-Baystate, Springfield, MA, United States.ORCID 0000-0002-8414-0507
Sharina PersonDivision of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0000-0001-9121-9566
Thomas K HoustonDepartment of Internal Medicine, Wake Forest University, Winston-Salem, NC, United States.ORCID 0000-0002-2909-4018
Megan E Gauvey-KernInstitute for Clinical and Translational Research, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.ORCID 0000-0003-1662-5243
Jackie LobienInstitute for Clinical and Translational Research, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.ORCID 0009-0001-8934-4576
Rajani S SadasivamDivision of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0000-0001-8406-6207
Kavitha BalakrishnanDivision of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID 0009-0005-8170-5604

Funding

Adapt2Quit – A Machine-Learning, Adaptive Motivational System: RCT for Socio-Economically Disadvantaged smokers”R01CA240551 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SADASIVAM, RAJANI · 2020 to 2024
$3.2M
NCI NIH HHS R01 CA240551
6 · The paper itself

Abstract

backgroundIndividuals who are socioeconomically disadvantaged have high smoking rates and face barriers to participating in smoking cessation interventions. Computer-tailored health communication, which is focused on finding the most relevant messages for an individual, has been shown to promote behavior change. We developed a machine learning approach (the Adapt2Quit recommender system), and our pilot work demonstrated the potential to increase message relevance and smoking cessation effectiveness among individuals who are socioeconomically disadvantaged.

objectiveThis study protocol describes our randomized controlled trial to test whether the Adapt2Quit recommender system will increase smoking cessation among individuals from socioeconomically disadvantaged backgrounds who smoke.

methodsIndividuals from socioeconomically disadvantaged backgrounds who smoke were identified based on insurance tied to low income or from clinical settings (eg, community health centers) that provide care for low-income patients. They received text messages from the Adapt2Quit recommender system for 6 months. Participants received daily text messages for the first 30 days and every 14 days until the end of the study. Intervention participants also received biweekly texting facilitation messages, that is, text messages asking participants to respond (yes or no) if they were interested in being referred to the quitline. Interested participants were then actively referred to the quitline by study staff. Intervention participants also received biweekly text messages assessing their current smoking status. Control participants did not receive the recommender messages but received the biweekly texting facilitation and smoking status assessment messages. Our primary outcome is the 7-day point-prevalence smoking cessation at 6 months, verified by carbon monoxide testing. We will use an inverse probability weighting approach to test our primary outcome. This involves using a logistic regression model to predict nonmissingness, calculating the inverse probability of nonmissingness, and using it as a weight in a logistic regression model to compare cessation rates between the two groups.

resultsThe Adapt2Quit study was funded in April 2020 and is still ongoing. We have completed the recruitment of individuals (N=757 participants). The 6-month follow-up of all participants was completed in November 2024. The sample consists of 64% (486/757) female participants, 35% (265/757) Black or African American individuals, 51.1% (387/757) White individuals, and 16% (121/757) Hispanic or Latino individuals. In total, 52.6% (398/757) of participants reported having a high school education or being a high school graduate; 70% (529/757) smoked their first cigarette within 30 minutes of waking, and half (379/757, 50%) had stopped smoking for at least one day in the past year. Moreover, 16.6% (126/757) had called the quitline before study participation.

conclusionsWe have recruited a diverse sample of individuals who are socioeconomically disadvantaged and designed a rigorous protocol to evaluate the Adapt2Quit recommender system. Future papers will present our main analysis of the trial.

trial registrationClinicalTrials.gov NCT04720625; https://clinicaltrials.gov/study/NCT04720625. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/63693.

Indexed as

Machine LearningMotivationSmokersSmoking CessationVulnerable PopulationsAdultFemaleHumansMaleMiddle AgedPovertyRandomized Controlled Trials as TopicText Messagingmachine learningmHealthsmoking cessationsocioeconomically disadvantaged, biochemical verification

Identifiers

PMID40239194
PMCPMC12044314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.